Luigi Mangione has an issue with another health insurance company — and it's not UnitedHealthcare
They say prosecutors sent Aetna an "unlawful," back-channel subpoena seeking his confidential insurance account number and the time period for his coverage — and that in response, Aetna mistakenly sent prosecutors Mangione's entire, 120-page insurance record.
This "trove of protected medical information" includes "different diagnoses as well as specific medical complaints made by Mr. Mangione," his lawyers complained in a court filing Thursday night.
New York prosecutors should never have had access to these private records, his lawyers contend. And they should never have looked at them once receiving them, they also argue.
Aetna emailed the records to the Manhattan District Attorney's Office on June 12, in four files, with a cover letter advising "confidential." Each file was separately labeled "in large-type bold letters 'Request for Protected Health Information," the lawyers wrote.
"It would be impossible for anyone to view a single page of these records and not immediately see that they were private, confidential medical records within the scope of HIPAA," the federal Health Insurance Portability and Accountability Act, the lawyers wrote.
The sheer volume of Aetna's response should have alerted prosecutors that "the unlawful subpoena they served on Aetna resulted in far more material than they requested," the lawyers wrote.
But instead of immediately sending the materials to the judge and the defense — where they should have been directly sent, as required by law — the DA's office says it downloaded them into an internal "discovery file," the lawyers wrote.
The lawyers say prosecutors "sat on this information" for 12 days, until June 24, when they sent the judge and defense team an email forwarding the four files. Prosecutors have told Mangione's lawyers that in the interim, they had reviewed the records, but not "in their entirety," according to the defense filing.
The defense filing, signed by defense lawyers Karen Friedman Agnifilo, Marc Agnifilo, and Jacob Kaplan, asks New York Supreme Court Justice Gregory Carro to order prosecutors to turn over all of their communications with Aetna.
It also asks the judge to hold "a full evidentiary hearing," with sworn testimony, to determine possible remedies, including the recusal of lead prosecutor Joel Seidemann, the suppression of evidence, and the dismissal of Mangione's indictment.
The subpoena, issued directly to Aetna and signed by Seidemann, bypassed the judge and defense team and should never have requested even the limited, HIPAA-protected information of Mangione's account number and period of coverage, his lawyers argue.
"If they're seeking information that is privileged, like medical records, the DA can't just subpoena that stuff directly," veteran homicide public defender Sam Roberts told Business Insider on Friday.
Prosecutors must first file a motion or application to the judge and defense team, alerting them to the subpoena, and then wait for the judge to review the subpoenaed materials privately, said Roberts, a senior staff attorney on the homicide defense task force of the Legal Aid Society.
"It sounds like they jumped the gun here," Roberts said. "They got this information without first giving notice to the defense, and they got the information directly from Aetna when they should have sent it to the court first without opening it."
Mangione's lawyers allege in their filing that the May 14 subpoena initially commanded Aetna to send someone to appear in court on May 23 with "the account number and period of time during which the following individual received coverage: Luigi Mangione."
The subpoena was not made public or viewed by BI.
May 23 was "a completely made-up date," on which no court proceeding was scheduled, Mangione's lawyers wrote.
Along with the subpoena, Seidemann sent a cover letter with his phone number and email, advising that "in lieu of appearing personally with the requested documents," Aetna could mail or deliver the records to the court, the lawyers wrote.
Prosecutors "were plainly lying to get the materials as soon as possible," they wrote, in order to bring their case to trial first, before he could be tried by federal prosecutors.
In addition to the state-level case, which alleges murder as an act of terrorism, Mangione is facing related, death-penalty-eligible murder charges in federal court. Prosecutors in central Pennsylvania say they, too, will try him for forgery and firearm charges related to his arrest there on December 9, after a five-day national manhunt.
Mangione's lawyers previously complained that in April, Manhattan prosecutors improperly listened to an 11-minute attorney-client phone call, something the DA's office has denied.
Both state and federal jurisdictions are vying to be first to put Mangione on trial.
Had Mangione's lawyers not been bypassed, they would have objected to the Aetna subpoena, including on the grounds that "the information sought is not relevant," they wrote.
A spokesperson for the DA's office told BI on Friday that they will respond to the defense allegations in court papers.
"Aetna received a subpoena for certain medical records, and we provided them appropriately," said Phil Blando, executive director for communications for Aetna's parent company, CVS Health.
Asked if the district attorney subpoena requested details beyond Mangione's account number and coverage period, Blando told BI in an email, "You have our statement."
Mangione, a 27-year-old software developer, remains in a federal jail in Brooklyn in the December 4 murder of Thompson.
The 50-year-old father of two from Minnesota was shot in the back at close range outside a Midtown hotel where he was about to address the UnitedHealthcare shareholders meeting.
Mangione is linked to the killing by his so-called "manifesto" and by DNA, ballistics, video, and fingerprint evidence, according to state and federal prosecutors.
He is next due in state court on September 16, and in federal court on December 5; both courts are in Manhattan.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
15 hours ago
- New York Post
Scotty Enoe's deserved acquittal proves it: Alvin Bragg hates citizens who dare to defend themselves
Three cheers for the Manhattan jury that quickly acquitted CVS clerk Scotty Enoe of manslaughter for defending himself and his fellow employees against a deranged serial shoplifter. This case should never have come to trial. Enoe should have been hailed as a hero instead of being charged by the execrable Manhattan District Attorney Alvin Bragg. Indeed, if there was ever a clear-cut case of self-defense, this was it. Enoe was attacked from behind by Charles Brito, who began to beat him savagely. Outmatched by the brute and fearing for his life, Enoe took out a small folding knife and stabbed him in the liver. Brito staggered onto the sidewalk and later died. Enoe's co-workers, too, they were afraid of Brito, who had threatened to kill someone, yet Bragg pursued the case anyway. We saw this with Jose Alba and Daniel Penny, both charged with manslaughter by Bragg when — in self-defense — they killed people who were violent, unstable and threatening them or others nearby. Bragg dropped the charges against Alba when public pressure became too great. Penny was acquitted. Keep up with today's most important news Stay up on the very latest with Evening Update. Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters The problem is that the DA believes crime is caused by social ills, and the attackers are the real victims. Cases like this one — and the leniency he's shown to real criminals — send a message that law-breakers are free to pursue their wicked calling, and citizens just have to sit back and take it. There's no other way to explain why he continues to charge hard-working New Yorkers and subway passengers with serious crimes when ugly situations are thrust upon them, while allowing criminals off easy. This Enoe acquittal drives home the point yet again: Alvin Bragg needs to go — ASAP. The sooner voters ditch him at the polls, the safer this city will become.
Chicago Tribune
15 hours ago
- Chicago Tribune
UnitedHealth says it is under a federal investigation and cooperating
UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading Medicare business. The health care giant said Thursday that it had contacted the Department of Justice after reviewing media reports about investigations into certain elements of its business. '(UnitedHealth) has a long record of responsible conduct and effective compliance,' the company said in a Securities and Exchange Commission filing. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. The Journal said in February, citing anonymous sources, that the probe focused on billing practices in recent months. The paper has since said that a federal criminal health care-fraud unit was investigating how the company used doctors and nurses to gather diagnoses that bolster payments. UnitedHealth said in the filing Thursday that it 'has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.' UnitedHealth Group Inc. runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. UnitedHealth raked in more than $400 billion in revenue last year to come in third in the Fortune 500 list of biggest U.S. companies. Its share price topped $630 last fall to reach a new all-time high. But the stock has mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. A suspect, Luigi Mangione, has been charged in connection with the shooting. In April, shares plunged some more after the company cut its forecast due to a spike in health care use. A month later, former CEO Andrew Witty resigned, and the company withdrew its forecast entirely, saying that medical costs from new Medicare Advantage members were higher than expected. The stock price was down more than 3%, or $10.73, to $281.78 Thursday afternoon. That represents a 55% drop from the all-time high it hit in November. Broader indexes were mixed. UnitedHealth will report its second-quarter results next Tuesday.
Yahoo
17 hours ago
- Yahoo
UnitedHealth stock sinks 4.7% after company confirms DOJ investigation into Medicare billing practices
UnitedHealth (UNH) stock fell 4.7% on Thursday after the insurance giant disclosed in a regulatory filing that it is facing an investigation from the Department of Justice into its Medicare billing practices. Following news reports from the Wall Street Journal about insurance billing techniques used by UnitedHealth and other large medical insurers, the Justice Department's healthcare fraud unit began making criminal and civil requests of the company, according to the filing. "The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process," UnitedHealth said in its disclosure. "The Company has a long record of responsible conduct and effective compliance." The insurer also said it has "proactively launched its own initiative to conduct third party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services." The Wall Street Journal's reporting, first published in December 2024, documented several ways in which United and other major insurers have received billions of dollars in extra payments from the federal Medicare Advantage system, which allows approved private companies to provide health benefits in lieu of the federally managed Medicare system. These include companies taking on extra, and sometimes incorrect, diagnoses to patient profiles when those rulings had not been made by the doctors actually treating the patients, allowing the insurers access to extra payouts from the Medicare program, among other tactics. The health insurance giant has been facing a probe from the Justice Department into possible Medicare fraud since at least the summer of 2024, according to the Wall Street Journal's reporting. UnitedHealth has been embroiled in a series of leadership controversies and financial setbacks over the last year, with its stock falling about 50% over that period. In May 2024, the company and several senior executives — including founder and group chairman Stephen Helmsley, and then-UnitedHealthcare CEO Brian Thompson — were sued by a Hollywood-based pension fund for insider trading in a lawsuit alleging executives sold more than $100 million in stock after the company found out it was facing an antitrust probe by the Department of Justice but before the investigation was publicly disclosed. Seven months later, in December, Thompson was shot and killed in Manhattan the morning of the company's annual investor meeting. Reactions across the country centered on anger toward UnitedHealthcare over its treatment of people on its insurance, including denial of claims. When the company reported earnings a month later, the results showed revenue missed analyst estimates and the insurer's medical care ratio — which measures how much of collected premiums are spent by the insurer on medical care — spiked. The stock dropped around 5% after the release. Three months later, the company's first quarter earnings report saw it slash its adjusted earnings per share guidance and sent shares down over 22%, its worst single-day performance since 1998. The next month, UnitedHealth's CEO Andrew Witty abruptly stepped down while the company pulled its annual forecast. Helmsley, who had previously moved to a role as group chairman, was quickly appointed as CEO to replace Witty. He was granted a pay package that includes a $1 million salary and $60 million in stock options that will vest after three years. That same month, the company suspended its annual forecast entirely, sending shares tumbling by roughly 16%. And in a final blow, UnitedHealth accidentally leaked a memo to STAT News in June that listed internal talking points on topics including the use of AI models to deny claims. Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at Click here for in-depth analysis of the latest stock market news and events moving stock prices
